Aspirion Expands Revenue Cycle Management Capabilities Through Strategic Acquisition of Boost Healthcare

Aspirion, the healthcare technology revenue cycle management (“RCM”) leader for denials, payment variance, and complex claims,…

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

 CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated…

Lab Automation Market to Hit USD 7.71 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™

The global lab automation market is expected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at…

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

 The Barbara Ann Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of…

Exero Medical Announces Enrollment of 100th Patient in Pivotal Study to Validate its Breakthrough Technology for Early Detection of Post Operative Complications

The study, which includes eleven sites in the US and Israel, is enrolling patients undergoing colorectal resection…

Health Commons Project Completes Acquisition of OneHealthPort to Advance Healthcare Innovation and Access across Washington State

 Health Commons Project, a leading nonprofit dedicated to improving healthcare access and quality through technology and…

Exactech Showcases Advanced Vitamin E Polyethylene and Technologies for Knee and Hip Replacement Surgery at AAHKS 2024

Exactech, a global medical technology leader, will showcase its advanced vitamin E polyethylene and latest total…

Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery,…

BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY 

 Over 80 million euros have been invested to build Hexagon, a new manufacturing facility located next to the…

Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences

Precision for Medicine, a leading next-generation provider of drug development and commercialization services, today announced the…